Skip to main content

What the FDA labels say about taking them together

Anagrelide and cilostazol

Anagrelide's FDA label of April 8, 2026 names cilostazol in its drug interactions section; the cilostazol label PlainMeds reads does not name anagrelide. The anagrelide label: “Avoid use of drug products with similar properties such as inotropes and other PDE3 inhibitors.”

Check it at the source: the anagrelide FDA label on DailyMed (effective April 8, 2026, Takeda Pharmaceuticals America, Inc.); the cilostazol FDA label on DailyMed (effective September 10, 2026, Apotex Corp.).

What does the anagrelide label say about cilostazol?

Anagrelide label, drug interactions

Avoid use of drug products with similar properties such as inotropes and other PDE3 inhibitors (e.g., cilostazol, milrinone) [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.2) ].

Source: FDA drug label (Agrylin), Takeda Pharmaceuticals America, Inc., effective April 8, 2026 (SPL set cb960074-99c1-4a73-941f-f0644a7ec219), via openFDA; the full label on DailyMed

What does the cilostazol label say about anagrelide?

Cilostazol's label (effective September 10, 2026) does not name anagrelide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (cilostazol), Apotex Corp., effective September 10, 2026 (SPL set ceac1ae3-c343-28ca-c083-b748d21a15e6), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Anagrelide generic labelers
9Cilostazol generic labelers
AnagrelideCilostazol
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)$0.729 per capsule 0.5 mg capsule$0.132 per tablet 100 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?